Dr. Caroline Golden is a postdoctoral researcher of Regius Professor Chris Toumazou at the Centre for Bio-Inspired Technology at Imperial College London. Her current research involves examining the efficacy of a DNA-based diet in reducing the risk of type 2 diabetes in pre-diabetic individuals, and to further assess if this intervention can be delivered using mobile and wearable technology. Her key aim is to translate cutting edge biotechnology research to real-world applications to help the public.
Her previous work has covered areas such as metal artifact reduction in CT imaging and models of deep brain stimulation on the ventral intermediate nucleus of the thalamus. She completed her PhD under the supervision of Dr. Paul Chadderton at Imperial College London. Her doctoral research focused on the neuronal correlates of working memory in awake mice, using in vivo multi-unit recordings and optogenetics. She also conducted research into the effects of the serotonergic agonist, psilocybin, on the prefrontal cortex in awake mice.
She is currently managing a clinical trial ASPIRE-DNA, details of which can be found here: